When was skyrizi approved?

When did Skyrizi get FDA approval?

Skyrizi (risankizumab) was first approved by the FDA on April 14, 2019, for the treatment of adults with moderate-to-severe plaque psoriasis.

Was Skyrizi approved earlier or only for psoriasis?

Skyrizi’s initial approval was for plaque psoriasis in adults. Later FDA approvals expanded its use to additional conditions, but the first overall FDA approval date remains April 14, 2019.

Source

• [1] https://www.drugpatentwatch.com/